<DOC>
	<DOCNO>NCT02301702</DOCNO>
	<brief_summary>Maternal immunization tetanus toxoid , reduce diphtheria toxoid , acellular pertussis vaccine ( Tdap ) potential strategy protect young infant pertussis fully vaccinate maternal antibody may cross placenta passively protect infant . The propose study randomize , blind , control , vaccine trial maternal Tdap vaccination third trimester pregnancy ( Tdap vaccination 27-36 week gestation ) . Pregnant woman recruit prenatal care clinic Hospital Nacional Occidente Health Centers Quetzaltenango , La Esperanza , San Juan Ostuncalco Concepción Chiquirichapa . Enrolled woman infant follow 7 month post-partum .</brief_summary>
	<brief_title>Maternal Tdap Immunization Guatemala</brief_title>
	<detailed_description>The propose study randomize , blind , control , vaccine trial maternal Tdap vaccination third trimester pregnancy ( Tdap vaccination 27-36 week gestation ) . Pregnant woman recruit prenatal care clinic Hospital Nacional de Occidente Health Centers Quetzaltenango , La Esperanza , San Juan Ostuncalco Concepción Chiquirichapa . All healthy pregnant woman age 18 40 year ( inclusive ) 27 week gestation later study area eligible participate study unless meet one exclusion criterion . Pregnant woman &lt; 27 week gestation pre-screened provide information study encourage enroll later pregnancy . Women eligible enrol obtain informed consent , randomize receive Tdap vaccine Td vaccine . Enrolled woman infant follow 7 month postpartum . To address primary objective , serum specimen collect mother prior receive study product ( Tdap Td ) , within 72 hour delivery 7 month post-partum . Moreover , infant specimen collect delivery ( cord blood infant blood within 72 hour birth ) , 2 month age ( prior first dose routine childhood DTwP series ) , 7 month age ( approximately 4 week third dose routine DTwP series ) . Infants give three dos pentavalent vaccine include DTwP vaccine 2 , 4 6 month ( routine childhood immunization ) recommend immunization schedule Guatemala 's National Immunization Program . Adverse event serious adverse event also monitor .</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Pregnant woman late second third trimester pregnancy ( i.e. , 27 week gestation ) , 2 . Between age 18 40 year ( inclusive ) , 3 . Intends remain study area least seven month delivery , 4 . Has access mobile phone ( define phone possession participant another family member life ) , 5 . Able provide inform consent . If participant illiterate , procedure ensure full understanding research consent process implement accord international federal guideline . 1 . History fever oral temperature ≥ 38.0 degree Celsius within 48 hour prior vaccination ( woman reevaluate subsequent visit ) , 2 . Received Tdap vaccine previous year , 3 . History serious systemic disease , include limited : GuillainBarré syndrome ; know HIV , hepatitis B , hepatitis C infection ; heart/lung disease ; uncontrolled diabetes mellitus ( include gestational diabetes ) ; chronic liver/kidney disease ; clinically significant neurological disorder . This information base selfreporting ( possible ) confirm health facility medical record . 4 . High risk pregnancy , identify Normas de Atención en Salud Integral , guideline document publish Ministry Health , also previous complicate pregnancy preterm delivery , spontaneous medical abortion , previous congenital anomaly , 5 . Received immunoglobulin blood product within precede 3 month ( exception Rhogam ) , 6 . History allergy component vaccine ( i.e . egg , egg protein , gelatin , formaldehyde , glutaraldehyde , polyethylene glycol pisooctylphenyl ether , sucrose , aluminum hydroxide , polysorbate 80 ) latex , 7 . History severe reaction ( include hypersensitivity ) receive vaccine , 8 . History evidence immunosuppression ( due illness treatment ) immunosuppressive therapy ( include long term use steroid ; use highdose inhaled steroid within past six month ; exception treatment betamethasone dexamethasone injection prevention lung immaturity last trimester pregnancy , 9 . In opinion study team would unsafe unsuitable pregnant mother fetus receive vaccine participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Maternal Immunization</keyword>
	<keyword>Tdap</keyword>
	<keyword>Td</keyword>
	<keyword>Pertussis</keyword>
</DOC>